Upregulated GBP2 exacerbates Parkinson's disease pathogenesis by impairing NIX-dependent mitophagy
Parkinson's disease (PD), characterized by dopaminergic neuron loss, still lacks disease-modifying therapies due to incompletely understood mechanisms. Guanylate-binding proteins (GBPs) are well-known immune regulators, but their roles in PD are largely unknown. In this study, we identify GBP2 as a...
Salvato in:
| Autori principali: | , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elsevier
2026-03-01
|
| Serie: | Redox Biology |
| Soggetti: | |
| Accesso online: | http://www.sciencedirect.com/science/article/pii/S2213231726000273 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|